IUCT-Oncopole Institut Universitaire du Cancer

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma	IDH1-mutant Glioma; IDH2-mutant Glioma	Active, not recruiting	Phase 1 / Phase 2	2026-07-08		NCT06478212
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen	Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm	Recruiting	Phase 3	2026-02-06		NCT06127407

Clinical trials